Pharmaceutical company Ipsen has appointed Dominique Laymand as chief ethics and compliance officer for the Ipsen group, effective as of March 16. She will report directly to Chairman and CEO Marc de Garidel.
Laymand previously was vice president of compliance and ethics of Bristol Myers Squibb (BMS). Since 2004, she set up and managed the compliance and ethics program at BMS for Europe, Middle East, Africa, Turkey, and Russia. This program is based on an integrated approach for supporting operational risks prevention and mitigation, as well as on high standards of business integrity. Laymand started at Bristol-Myers Squibb in 1983 as legal counsel, France. She then held various responsible positions in the company's law department.